Cardiogenic Shock Management and Research: Past, Present, and Future Outlook

Area of Science:

• Cardiology
• Critical Care Medicine

Background:

• Cardiogenic shock (CS) continues to have high morbidity and mortality rates.
• Acute myocardial infarction (MI) is the most frequent cause of CS, but other acute heart failure phenotypes also exist.

Purpose of the Study:

• To review the history, landmark trials, and current management strategies for cardiogenic shock.
• To discuss medical therapies, mechanical circulatory support, and future perspectives in CS management.

Main Methods:

• Literature review of cardiogenic shock management.
• Discussion of historical context, clinical trials, and therapeutic options.

Main Results:

• Despite progress, evidence for many current CS treatment regimens is limited.
• Implementing large-scale randomized controlled trials for CS is challenging.

Conclusions:

• Optimizing cardiogenic shock management requires further research and robust clinical trials.
• Future perspectives focus on advancing medical therapy and mechanical circulatory support for improved patient survival.